Question:
Tamoxifen is nonsteroidal drug acting at steroid receptor(s) It produces which type of effects
(P) Androgen (Q) Antiestrogen (R) Antiprogestogen (S) Estrogen
Tamoxifen is nonsteroidal drug acting at steroid receptor(s) It produces which type of effects
| (P) Androgen | (Q) Antiestrogen | (R) Antiprogestogen | (S) Estrogen |
Updated On: Apr 28, 2025
- P and Q
- Q and S
- Q and R
- R and S
Hide Solution
Verified By Collegedunia
The Correct Option is B
Solution and Explanation
The correct option is (B) :Q and S
Was this answer helpful?
0
0
Top Questions on Lipids
- Which of the following is a Partial Fatty acid oxidation (pFox) inhibitor:
- With reference to disinfection, which of the following statement(s) is/are CORRECT?
- Which of the following is a Partial Fatty acid oxidation (pFox) inhibitor:
- Eicosanoids are polyunsaturated fatty acids of _____ carbons:
- Which one of the following is NOT a phospholipid?
View More Questions
Questions Asked in GPAT exam
- Match the following:
(P) Schedule H
(Q) Schedule G
(R) Schedule P
(S) Schedule F2
Descriptions:
(I) Life period of drugs
(II) Drugs used under RMP
(III) List of Prescription Drugs
(IV) Standards for surgical dressing- GPAT - 2025
- Drug therapy
- Minimum manufacturing space for 'Habb-Unani medicine' as per Schedule of D and C Act?
- GPAT - 2025
- Pharma Techniques
- If the label or the container bears the name of an individual or company purporting to be the manufacturer of the drug, which individual or company is fictitious or does not exist, it is:
- GPAT - 2025
- Drug therapy
- Match the following:
(1) Schedule FF
(2) Schedule F3
(3) Schedule V
(4) Schedule Y
Descriptions:
(P) Standards of patent and proprietary medicines
(Q) Requirements and guidelines for clinical trials
(R) Standards for sterilized umbilical tapes
(S) Standards for Ophthalmic preparations- GPAT - 2025
- Drug therapy
Match the following Class and their Drug:
(1) Alkylating (P) 5-fluorouracil
(2) Platinum analog (Q) Cisplatin
(3) Antimetabolite (R) Cetuximab
(4) EGF receptor inhibitor (S) Chlorambucil- GPAT - 2025
- Biostatistics and Research Methodology
View More Questions